Valuation China Shineway Pharmaceutical Group Limited OTC Markets

Stocks

Market Closed - OTC Markets 15:15:08 2025-05-13 EDT			5-day change	1st Jan Change
19.25 ^USD	+3.89%		-.--%	-

08-27	China Shineway Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June 30, 2026	CI
08-27	China Shineway Pharmaceutical Group Limited Declares Second Interim Dividend in Respect of the Fiscal Year Ended December 31, 2026, Payable on 25 September 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	4,240	5,072	4,985	6,850	5,838	5,137	-	-
Change	-	19.61%	-1.71%	37.41%	-14.78%	-12.01%	-	-
Enterprise Value (EV)	49.32	25.13	4,985	6,850	5,838	5,137	5,137	5,137
Change	-	-49.04%	19,734.74%	37.41%	-14.78%	-12.01%	0%	0%
P/E	7.59x	6.99x	5.16x	8.17x	6.13x	6.8x	6.33x	5.95x
PBR	0.72x	0.79x	0.71x	-	0.72x	0.65x	-	-
PEG	-	0.2x	0.2x	-0.6x	0.5x	-0.3x	0.86x	0.93x
Capitalization / Revenue	1.32x	1.28x	1.1x	1.81x	1.86x	2.19x	2.19x	2.12x
EV / Revenue	0x	0x	0x	0x	0x	2.19x	2.19x	2.12x
EV / EBITDA	0x	0x	0x	0x	0x	6.32x	5.94x	5.64x
EV / EBIT	0x	0x	0x	0x	0x	6.32x	5.94x	5.64x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	0.39	0.32	0.42	0.54	-	-	-	-
Rate of return	6.95%	4.77%	6.36%	5.95%	-	-	-	-
EPS ²	0.74	0.96	1.28	1.11	1.26	1	1.074	1.143
Distribution rate	52.7%	33.3%	32.8%	48.6%	-	-	-	-
Net sales ¹	3,224	3,951	4,517	3,778	3,135	2,344	2,347	2,427
EBITDA ¹	826	1,022	1,316	1,306	1,047	813	865	911
EBIT ¹	643.6	835.8	1,139	1,025	896	813	865	911
Net income ¹	556.7	722.8	969.5	840.1	949.9	755	811	864
Net Debt	-4,191	-5,046	-	-	-	-	-	-
Reference price ²	5.613	6.714	6.599	9.068	7.728	6.800	6.800	6.800
Nbr of stocks (in thousands)	755,400	755,400	755,400	755,400	755,400	755,400	-	-
Announcement Date	3/29/22	3/30/23	3/28/24	3/28/25	3/27/26	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	33.95x	6.37x	22.05x	0.93%	46.21B
OTSUKA HOLDINGS CO., LTD.	16.25x	2.01x	8.92x	1.63%	38.78B
ZYDUS LIFESCIENCES LIMITED	26.83x	3.84x	15.91x	0.6%	11.68B
CIPLA LIMITED	26.59x	3.22x	16.68x	0.95%	11.55B
KRKA, D. D.	18.58x	3.37x	11.75x	3.79%	9.14B
GEDEON RICHTER	9.22x	2.13x	5.5x	4.82%	7.3B
GLENMARK PHARMACEUTICALS LIMITED	29.42x	3.85x	17.9x	0.16%	7.15B
ONO PHARMACEUTICAL CO., LTD.	14.96x	1.94x	6.45x	3.37%	7.1B
Average	21.98x	3.34x	13.15x	2.03%	17.36B
Weighted average by Cap.	24.29x	3.90x	14.87x	1.58%